About Lyndra Therapeutics
Lyndra Therapeutics is a private company based in Watertown, Massachusetts. It has reported $281,896,461 raised in five offerings on Form D since July 2016. Its chief executive is Jessica Ballinger.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 2023 | Dec 29, 2023 | $122,749,667of $206.0M target | 16 | $7.6M | Equity, OptionsRule 506(b) | Form D ↗ |
| May 23, 2023 | Jun 7, 2023 | $20,350,715of $179.2M target | 7 | $2.9M | Equity, OptionsRule 506(b) | Form D ↗ |
| Jun 8, 2021 | Jun 23, 2021 | $60,470,112of $65.0M target | 22 | $2.7M | EquityRule 506(b) | Form D ↗ |
| Jan 11, 2019 | Jan 28, 2019 | $55,243,392of $60.9M target | 23 | $2.4M | EquityRule 506(b) | Form D ↗ |
| Jun 22, 2016 | Jul 13, 2016amended Apr 19, 2017 | $23,082,575fully sold | 15 | $1.5M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Total, five offerings | $281,896,461 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lyndra Therapeutics's Form D filed Dec 29, 2023.
ZA
Zafi Avnur
Director
AS
Ashish Singh
Director
JB
Jessica Ballinger
Chief Executive Officer and director
RL
Robert Langer
Director
DD
Doug Dachille
Director
AS
Amy Schulman
Director
PH
Patricia Hurter
Director
CR
Catherine Reynolds
Director
HM
Helene Madonick
Director
CT
Carlo Traverso
Director
Earlier filings also listed Jillian Moo-Young (director, last listed Jun 2023) and Edmund Harrigan (director, last listed Jan 2019).